Thank You to our Leadership Donors

The Endocrine Society would like to recognize the 2009 Leadership Donors. Leadership Donors have contributed $100,000 or more to The Endocrine Society’s activities, with at least $50,000 dedicated to educational programming.

Diamond
Abbott Laboratories
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Novo Nordisk Inc.
Solvay Pharmaceuticals, Inc.

Platinum
Amgen
Genentech
Lilly USA, LLC
Pfizer, Inc.

Gold
Takeda Pharmaceuticals North American, Inc.

Silver
Ipsen

The Endocrine Society would like to thank the following companies
for their support throughout the year:

Allergan
Amylin Pharmaceuticals, Inc., and Lilly USA, LLC
AstraZeneca
Auxilium Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Bristol-Myers Squibb
Bristol-Myers Squibb and AstraZeneca
Daiichi Sankyo, Inc.
EMD Serono, Inc.
Endo Pharmaceuticals
Genzyme Corporation
GlaxoSmithKline
Medtronic Diabetes
Medtronic Diabetes/LifeScan Alliance
Merck/Schering Plough
Roche Laboratories
sanofi-aventis, U.S., Inc.
Wyeth Pharmaceuticals

All of The Endocrine Society’s educational program content is developed by The Endocrine Society prior to and independent of education grant support. In accordance with the standards of the ACCME, the commercial supporters of CME accredited educational programs have had no influence in the identification and selection of presentation topics or speakers.